Similares a Inside the VESPER-3 Results: Berobenatide's Weight Loss Potential

20 vecinos (text_768) · 839 views · HCPLive · Estados Unidos


★	Inside the VESPER-3 Results: Berobenatide's Weight Loss Potential	HCPLive @hcplivenews	839	Estados Unidos
15	The Cholesterol War Is Over (Here's Who Won)	Dr Brad Stanfield @drbradstanfield	147.6K	Nueva Zelanda	86
19	Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D	HCPLive @hcplivenews	1.6K	Estados Unidos	86
6	Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight	HCPLive @hcplivenews	1.1K	Estados Unidos	87
7	GLP-1 Therapies: Where We’ve Been & Where We’re Going	Conversations on Health Care @cohcpodcast	541	Estados Unidos	86
2	Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss	HCPLive @hcplivenews	533	Estados Unidos	89
17	Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B	HCPLive @hcplivenews	521	Estados Unidos	86
4	TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity	HCPLive @hcplivenews	350	Estados Unidos	88
10	3 things you need to know about Tirzepatide for weight loss.	MurgaSkin Labs @murgaskinlabs	317	—	86
1	Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss	HCPLive @hcplivenews	250	Estados Unidos	96
16	Diabetes Dialogue: Weekly Insulin Icodec Now Available for Type 2 Diabetes	HCPLive @hcplivenews	206	Estados Unidos	86
9	SYNCHRONIZE-1: Survodutide Achieves Significant Weight Loss Versus Placebo	HCPLive @hcplivenews	174	Estados Unidos	86
8	Rapid Evolution in GLP-1s and Therapeutics at ADA 2026	HCPLive @hcplivenews	171	Estados Unidos	86
3	Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3	HCPLive @hcplivenews	158	Estados Unidos	88
18	Diabetes Dialogue: CONNECT, TRANSCEND, and TRIUMPH at ADA 2026	HCPLive @hcplivenews	114	Estados Unidos	86
14	Could Obesity Treatments Last 3 Months?	WebsEdgeMedicine @websedgemedicine	104	—	86
11	Incretins, Monitors, and Insulin Titration at ADA 2026	HCPLive @hcplivenews	76	Estados Unidos	86
12	Diabetes Dialogue: Signos and the Science of Weight Loss	HCPLive @hcplivenews	75	Estados Unidos	86
13	#62: GLP-1s: Life-Changing Results… at What Cost?	Live Long and Well With Dr. Bobby @drbobbylivelongandwell	56	Estados Unidos	86
20	Ersodetug Shows Target Engagement but Misses Primary Endpoints in Phase 3 cHI Study	HCPLive @hcplivenews	20	Estados Unidos	86
5	Structuring Obesity Trials to Optimize Patient Retention and Data Integrity	HCPLive @hcplivenews	18	Estados Unidos	87